As per the research conducted by GME, the Point of Care/ At-Home Thyroid Diagnosis Market will grow with a CAGR value of 6.5 percent. The rising geriatric patient population across both developed and developing regions will also boost the demand for testing kits in the market. Also, with the increasing cases of thyroid patients, and increasing demand for point of care testing due to COVID-19 limitations on social distancing, the market for at-home thyroid diagnosis will be growing the fastest from 2021 to 2026
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Point of Care/ At-Home Thyroid Diagnosis Market- Forecast to 2026"
https://www.globalmarketestimates.com/market-report/global-point-of-care-at---home-thyroid-diagnosis-market-2924
By Type of Biomarkers (Complete Thyroid Profiling [Free T3, T4, TSH], Thyroid Peroxidase Antibodies [TPO/TPEX], Thyroglobulin Antibodies [TGAB], and Thyrotropin-Releasing Hormone [TRH]), By Application (Hypothyroidism [Hashimoto’s Disease], Hyperthyroidism [Graves’ Disease], and Other Applications), By Patient Gender (Male & Female Patients and Only Female Patients), By Product Type (At-Home Thyroid Diagnostic Kit, and At-Home Thyroid Sample Collection Kit), By Sample Collection Technique (Finger Prick and Blood Sample), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis
Key Market Insights
· The market for the at-home thyroid diagnostic kit will be growing faster than the collection kit owing to the advantagesof screening for the disorders at home
· The market segment of complete thyroid profiling will possess a larger share than other segment from 2021 to 2026
· The market for finger prick will be the largest because most of the commercialized at-home testing products offer finger prick sample collection techniques
· Everlywell, Paloma, LetsGetChecked, Imaware, Personal Diagnostics, PRIMA Lab SA, HomeCheck, healthconfirm, CVS Pharmacy, Doctorcall, Medichecks, PlushCare, Zavamed, Valuemed, and Thriva among others are the players in the point of care/ at-home thyroid diagnosis market
Browse the Report @ https://www.globalmarketestimates.com/market-report/global-point-of-care-at---home-thyroid-diagnosis-market-2924
Type of Biomarker Outlook (Revenue, USD Billion, 2021-2026)
· Complete Thyroid Profiling [Free T3, T4, TSH]
· Thyroid Peroxidase Antibodies [TPO/TPEX]
· Thyroglobulin Antibodies [TGAB]
· Thyrotropin-Releasing Hormone [TRH]
Application Outlook (Revenue, USD Billion, 2021-2026)
· Hypothyroidism [Hashimoto’s Disease]
· Hyperthyroidism [Graves’ Disease]
· Other Applications
Patient Gender Outlook (Revenue, USD Billion, 2021-2026)
· Male & Female Patients
· Only Female Patients
Product Type Outlook (Revenue, USD Billion, 2021-2026)
· At-Home Thyroid Diagnostic Kit
· At-Home Thyroid Sample Collection Kit
Sample Collecting Technique Outlook (Revenue, USD Billion, 2021-2026)
· Finger Prick
· Blood Sample
Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
The U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Rest of APAC
Central & South America
Brazil
Argentina
Rest of CSA
Middle East & Africa
Saudi Arabia
UAE
Rest of MEA
Contact: Tracy Simon
Email address: tracy.simon@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
Industries
Reports
Services
Newsroom
Next-Gen Expertise About Us
Contact Us
Blog
Category Healthcare
Format
Request Free
Sample
Buy Now
Point of Care/ At-Home Thyroid Diagnosis Market Insights
After the corona virus hit the world, most healthcare organizations started indulging in promoting
home-based testing methodologies for common lifestyle disorders. With the products such as home-
basedsugar tests or home-basedblood oxygen tests, the industry is also witnessing a rising demand for
home-basedthyroid testing kits or devices.Considering this trend, most of the point of care
manufacturers have taken a keen interest in pro-actively launching home-basedtesting kits and also
indulging in organic growth strategies such as product launch and geographical expansion through
partnerships and collaboration.These rapid, highly portable, and compact home-based thyroid testscan
give results for the diagnosis of hypo or hyperthyroidism. Some of the top companies involved in
offering home-based diagnostic kits are Everlywell, Paloma, Lets Get Checked, and I m aware, among
others.
The most vital or important part of the growth hormones are the thyroxine and triiodothyronine
hormone and its secretory gland is called the thyroid gland. As per the latest statistics by the WHO, as
of 2019, ~10% of the population residing in the US is living with some form of thyroid disorder,
whereas awareness regarding the same is only known to half of these people. Hence, with the rising
cases of thyroid patients, and increasing demand for point of care testing due to COVID-19 limitations
on social distancing, the market for at-home thyroid diagnosis will be growing the fastest from 2021 to
2026.
These kits not only test the TSH level but also offer free T3 and free T4, along with thyroid antibodies
test options such as Thyroid peroxidase antibodies (TPO/TPEX) and Thyroglobulin antibodies (TGAB).
Furthermore, thyroid related disease has lately affected most of the female population who are aged
above 60. Hence, the rising geriatric patient